הקסאקפרון להזרקה - Hexakapron injection
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | B02AA Amino acids | |||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-×ר××× - I.V | |||||
| צ×רת ××× ×× | ת×××¡× ×××רק×, SOLUTION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year.Specific indications include:- Haemorrhage caused by general or local fibrinolysis such as: * Menorrhagia and metrorrhagia * Gastrointestinal bleeding * Haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract- Ear Nose Throat surgery (adenoidectomy, tonsillectomy, dental extractions)- Gynaecological surgery or disorders of obstetric origin- Thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery- Management of haemorrhage due to the administration of a fibrinolytic agent. | |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| ×קס×קפר×× ××××¨×§× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL |
| ×©× ××¢× ×ר×ש×× | TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 01/2008. ר×ש××× ×ת×ר××: 01/2011 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
ת××× ×ª ×ר×××